Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00525460 · ClinicalTrials.gov registry record
Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 16
- Enrollment target
NCT00525460: Completed study, sponsored by Dana-Farber Cancer Institute.
NCT00525460 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00525460 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to ask youn women diagnosed with ovarian cancer who have undergone surgery that will allow them to have children in the future, on issues such as: education about their options to keep their ability to have children, after-chemotherapy treatment decision making, and reproductive history. The second purpose is to determine the effect of an early diagnosis of ovarian cancer on the sexual functioning of women.
Interventions
- BEHAVIORAL Fertility-Sparing Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-04 |
| Est. Completion | 2014-12 |
What the finished NCT00525460 record still lists
NCT00525460 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fertility-Sparing Survey is the first listed.
NCT00525460 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00525460 about?
NCT00525460 is a clinical study titled "Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function". The purpose of this study is to ask youn women diagnosed with ovarian cancer who have undergone surgery that will allow them to have children in the future, on issues such as: education about their options to keep their ability to have children, after-chemotherapy treatment decision making, and repr...
What is the current status of trial NCT00525460?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2006-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00525460?
The interventions under investigation include: Fertility-Sparing Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT00525460?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia